Recombinant Human SOCS1 Protein，His

Suppressor of Cytokine Signaling 1 (SOCS1) is a key protein in the regulation of cytokine signaling pathways, particularly those involving interleukin-6 (IL-6) and interferon-gamma (IFN-γ). As a member of the SOCS family, SOCS1 plays a crucial role in maintaining immune homeostasis by inhibiting the JAK/STAT signaling cascade, which is vital for cell proliferation, differentiation, and survival. Dysregulation of SOCS1 expression has been implicated in various pathological conditions, including autoimmune diseases, chronic inflammation, and cancer. Research into recombinant SOCS1 has gained traction due to its potential therapeutic applications, as understanding its structure and function may lead to novel strategies to modulate immune responses. Studies have shown that restoring SOCS1 activity could suppress aberrant signaling in tumor microenvironments, providing insights into cancer therapies. Moreover, SOCS1's ability to fine-tune immune responses offers promising avenues for treating inflammatory diseases. Investigating the recombinant production and functional assays of SOCS1 can help elucidate the molecular mechanisms behind its action and pave the way for innovative biological drugs. The ongoing exploration of SOCS1 not only enhances our understanding of cytokine signaling but also positions it as a critical target in the development of targeted therapies for various immune-related disorders.